63 related articles for article (PubMed ID: 17404030)
1. Effect of paclitaxel on intracellular localization of c-Myc and P-c-Myc in prostate carcinoma cell lines.
Supino R; Favini E; Cuccuru G; Zunino F; Scovassi AI
Ann N Y Acad Sci; 2007 Jan; 1095():175-81. PubMed ID: 17404030
[TBL] [Abstract][Full Text] [Related]
2. Role of c-myc protein in hormone refractory prostate carcinoma: cellular response to paclitaxel.
Cassinelli G; Supino R; Zuco V; Lanzi C; Scovassi AI; Semple SC; Zunino F
Biochem Pharmacol; 2004 Sep; 68(5):923-31. PubMed ID: 15294455
[TBL] [Abstract][Full Text] [Related]
3. Zinc deficiency reduces paclitaxel efficacy in LNCaP prostate cancer cells.
Killilea AN; Downing KH; Killilea DW
Cancer Lett; 2007 Dec; 258(1):70-9. PubMed ID: 17905512
[TBL] [Abstract][Full Text] [Related]
4. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
[TBL] [Abstract][Full Text] [Related]
5. Effects of sphingosine-1-phosphate and sphingosylphosphorylcholine on intracellular Ca2+ and cell death in prostate cancer cell lines.
Mulders AC; Nau S; Li Y; Michel MC
Auton Autacoid Pharmacol; 2007 Oct; 27(4):173-9. PubMed ID: 18076478
[TBL] [Abstract][Full Text] [Related]
6. Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells.
Skvortsova I; Skvortsov S; Stasyk T; Raju U; Popper BA; Schiestl B; von Guggenberg E; Neher A; Bonn GK; Huber LA; Lukas P
Proteomics; 2008 Nov; 8(21):4521-33. PubMed ID: 18821526
[TBL] [Abstract][Full Text] [Related]
7. The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines.
Takeda M; Mizokami A; Mamiya K; Li YQ; Zhang J; Keller ET; Namiki M
Prostate; 2007 Jun; 67(9):955-67. PubMed ID: 17440963
[TBL] [Abstract][Full Text] [Related]
8. Protein expression and intracellular localization of prostate apoptosis response-4 (Par-4) are associated with apoptosis induction in nasopharyngeal carcinoma cell lines.
Lee JW; Lee KF; Hsu HY; Hsu LP; Shih WL; Chu YC; Hsiao WT; Liu PF
Cancer Lett; 2007 Nov; 257(2):252-62. PubMed ID: 17881119
[TBL] [Abstract][Full Text] [Related]
9. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A
Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422
[TBL] [Abstract][Full Text] [Related]
10. Reduced tumor growth in vivo and increased c-Abl activity in PC3 prostate cancer cells overexpressing the Shb adapter protein.
Davoodpour P; Landström M; Welsh M
BMC Cancer; 2007 Aug; 7():161. PubMed ID: 17697368
[TBL] [Abstract][Full Text] [Related]
11. Proapoptotic compound ARC targets Akt and N-myc in neuroblastoma cells.
Radhakrishnan SK; Halasi M; Bhat UG; Kurmasheva RT; Houghton PJ; Gartel AL
Oncogene; 2008 Jan; 27(5):694-9. PubMed ID: 17724478
[TBL] [Abstract][Full Text] [Related]
12. Apoptotic mechanism of paclitaxel-induced cell death in human head and neck tumor cell lines.
Hsiao JR; Leu SF; Huang BM
J Oral Pathol Med; 2009 Feb; 38(2):188-97. PubMed ID: 19200178
[TBL] [Abstract][Full Text] [Related]
13. The effect of p53 gene expression on the inhibition of cell proliferation by paclitaxel.
Sakashita F; Osada S; Takemura M; Imai H; Tomita H; Nonaka K; Takahashi T; Seishima M
Cancer Chemother Pharmacol; 2008 Aug; 62(3):379-85. PubMed ID: 17960385
[TBL] [Abstract][Full Text] [Related]
14. Low doses of paclitaxel potently induce apoptosis in human retinoblastoma Y79 cells by up-regulating E2F1.
Drago-Ferrante R; Santulli A; Di Fiore R; Giuliano M; Calvaruso G; Tesoriere G; Vento R
Int J Oncol; 2008 Oct; 33(4):677-87. PubMed ID: 18813780
[TBL] [Abstract][Full Text] [Related]
15. Epothilone-paclitaxel resistant leukemic cells CEM/dEpoB300 are sensitive to albendazole: Involvement of apoptotic pathways.
Khalilzadeh A; Wangoo KT; Morris DL; Pourgholami MH
Biochem Pharmacol; 2007 Aug; 74(3):407-14. PubMed ID: 17560963
[TBL] [Abstract][Full Text] [Related]
16. GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen-independent prostate cancer.
Narita S; So A; Ettinger S; Hayashi N; Muramaki M; Fazli L; Kim Y; Gleave ME
Clin Cancer Res; 2008 Sep; 14(18):5769-77. PubMed ID: 18794086
[TBL] [Abstract][Full Text] [Related]
17. Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines.
Ho TF; Peng YT; Chuang SM; Lin SC; Feng BL; Lu CH; Yu WJ; Chang JS; Chang CC
Toxicol Appl Pharmacol; 2009 Mar; 235(2):253-60. PubMed ID: 19133282
[TBL] [Abstract][Full Text] [Related]
18. Human cytomegalovirus infection alters PC3 prostate carcinoma cell adhesion to endothelial cells and extracellular matrix.
Blaheta RA; Weich E; Marian D; Bereiter-Hahn J; Jones J; Jonas D; Michaelis M; Doerr HW; Cinatl J
Neoplasia; 2006 Oct; 8(10):807-16. PubMed ID: 17032497
[TBL] [Abstract][Full Text] [Related]
19. Platycodin D induces apoptosis and decreases telomerase activity in human leukemia cells.
Kim MO; Moon DO; Choi YH; Shin DY; Kang HS; Choi BT; Lee JD; Li W; Kim GY
Cancer Lett; 2008 Mar; 261(1):98-107. PubMed ID: 18093727
[TBL] [Abstract][Full Text] [Related]
20. Pectenotoxin-2 represses telomerase activity in human leukemia cells through suppression of hTERT gene expression and Akt-dependent hTERT phosphorylation.
Kim MO; Moon DO; Kang SH; Heo MS; Choi YH; Jung JH; Lee JD; Kim GY
FEBS Lett; 2008 Oct; 582(23-24):3263-9. PubMed ID: 18775701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
